JM VASCULAR US LIMITED

Company Registration Number:
10064955 (England and Wales)

Unaudited micro entity accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

JM VASCULAR US LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

JM VASCULAR US LIMITED

Company Information

for the Period Ended 31 March 2025




Director: Jessica Matchan
Registered office: The Garden
Homend Crescent
Ledbury
Herefordshire
England
HR8 1AQ
Company Registration Number: 10064955 (England and Wales)

JM VASCULAR US LIMITED

Directors' Report Period Ended 31 March 2025

The directors present their report with the financial statements of the company for the period ended 31 March 2025

Principal Activities

Provision of Vascular Ultrasound Service

Directors

The directors shown below have held office during the whole of the period from 01 April 2024 to 31 March 2025
Jessica Matchan

This report was approved by the board of directors on 29 December 2025
And Signed On Behalf Of The Board By:

Name: Jessica Matchan
Status: Director

JM VASCULAR US LIMITED

Profit and Loss Account

for the Period Ended 31 March 2025


2025
£

2024
£
Turnover 12,324 17,195
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 25 0
Cost of Materials ( 0 ) ( 0 )
Staff Costs ( 918 ) ( 1,220 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Other charges ( 102 ) ( 100 )
Tax on Profit ( 2,153 ) ( 3,017 )
Profit or (Loss) for Period 9,176 12,858

JM VASCULAR US LIMITED

Balance sheet

As at 31 March 2025


2025
£

2024
£
Called up share capital not paid: 0 0
Fixed Assets: 0 0
Current assets: 18,191 25,684
Prepayments and accrued income: 3,204 0
Creditors: amounts falling due within one year: ( 2,153 ) ( 3,017 )
Net current assets (liabilities): 19,242 22,667
Total assets less current liabilities: 19,242 22,667
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 2,598 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 16,644 22,667
Capital and reserves: 16,644 22,667

JM VASCULAR US LIMITED

Balance sheet continued

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 29 December 2025
And Signed On Behalf Of The Board By:

Name: Jessica Matchan
Status: Director

The notes form part of these financial statements

JM VASCULAR US LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Employee Information

    Average number of employees: 0

JM VASCULAR US LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Off balance sheet disclosure

    No

JM VASCULAR US LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2025

  • 3. Advances and credits

    During the year the director (J Matchan) entered into the following advances and credits with the company:

    Year ended 31/03/2024


    Dividends
    Dividends paid and proposed on equity shares:
    Paid during the year: £15200
    Equity dividends on ordinary shares (£15200)



    Creditors (amounts falling due within 1 year):
    Corporation tax: £2153
    Creditors: £2153

    Share capital:
    Authorised:
    100 ordinary shares of £1 each
    Equity shares:
    100 ordinary shares of £1 each

    Capital and reserves
    Called up share capital: £100
    Reserves:£22667
    Profit and loss account: £9177.15 (when using actual figures)
    Shareholders' funds: £16644